Keywords
comorbidity of arterial hypertension
clinical and laboratory characteristics
clinical and instrumental characteristics
caspase-8
How to Cite
Abstract
The article defines the clinical-laboratory and clinical-instrumental features of the comorbid course of chronic obstructive pulmonary disease (COPD) and hypertension (HTN). The aim of the study was to determine the clinical, laboratory and instrumental features of the comorbid course of COPD and HTN. The study was carried out in accordance with the existing recommendations of bioethical norms and rules. All patients took part in the study of their own free will with the signing of informed consent. 125 patients aged 18–50 years were examined, who were divided into 3 groups: group I – 48 patients with COPD and HTN, group II – 47 patients with an isolated course of COPD, group III (control) – 30 practically healthy people. Medical and statistical calculation was performed using the IBM SPSS 25.0 software package. Calculated median (Me) levels and their 25.0% (LQ) and 75.0% (UQ) quartiles. The probability of differences was determined using the Man-Whitney U-test with a statistical significance threshold of 0.05 (p=0.05). According to the results of the study, an excess of systolic and diastolic blood pressure levels was significantly stated in comorbidity of COPD and HTN and in patients with isolated COPD. The presence of lymphocytopenia and monocytosis in such patients has been reliably established and significant protein loss in COPD has been determined. Significant predominances of biochemical values of the blood of patients with comorbidity of COPD and HNT and with isolated COPD compared to the control were significantly recorded. Significant decreases in the levels of external respiratory function in COPD (especially in its comorbidity with HNT) were noted and a significant predominance of Caspase-8 levels was determined in the following patients: in comorbidity of COPD and HTN – 3.79 [3.57; 3.84] U/l and in isolated COPD – 3.48 [2.99; 3.72] U/l.
Keywords: patients with chronic obstructive pulmonary disease, comorbidity of arterial hypertension, clinical and laboratory characteristics, clinical and instrumental characteristics, caspase-8.
References
Greulich T, Weist BJD, Koczulla AR, Janciauskiene S, Klemmer A, Lux W, et al. Prevalence of comorbidities in COPD patients by disease severity in a German population. Respir Med. 2017;132:132-8. DOI: 10.1016/j.rmed.2017.10.007. PMID: 29229085.
Tang Y, Cai QH, Wang YJ, Fan SH, Zhang ZF, Xiao MQ, et al. Protective effect of autophagy on endoplasmic reticulum stress induced apoptosis of alveolar epithelial cells in rat models of COPD. Biosci Rep. 2017;37(6):BSR20170803. DOI: 10.1042/BSR20170803. PMID: 28963374.
Bewley MA, Preston JA, Mohasin M, Marriott HM, Budd RC, Swales J, et al. Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages. Am J Respir Crit Care Med. 2017;196(7):845-5. DOI: 10.1164/rccm.201608-1714OC. PMID: 28557543.
Mendy A, Forno E, Niyonsenga T, Gasana J. Blood biomarkers as predictors of long-term mortality in COPD. Clin Respir J. 2018;12(5):1891-9. DOI: 10.1111/crj.12752. PMID: 29227024.
Mizumura K, Maruoka S, Shimizu T, Gon Y. Autophagy, selective autophagy, and necroptosis in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3156-72. DOI: 10.2147/COPD.S175830. PMID: 30349225.
Liu X, Ma C, Wang X, Wang W, Li Z, Wang X, et al. Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model. Int J Chron Obstruct Pulmon Dis. 2017;12:1309-24. DOI: 10.2147/COPD.S124547. PMID: 28496315.
Yin HL, Yin SQ, Lin QY, Xu Y, Xu HW, Liu T. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis. Medicine (Baltimore). 2017;96(19):e6836. DOI: 10.1097/MD.0000000000006836. PMID: 28489768.
Kadota T, Fujita Y, Yoshioka Y, Araya J, Kuwano K, Ochiya T. Extracellular Vesicles in Chronic Obstructive Pulmonary Disease. Int J Mol Sci. 2016;17(11):1801. DOI: 10.3390/ijms17111801. PMID: 27801806.
Vij N, Chandramani-Shivalingappa P, Van Westphal C, Hole R, Bodas M. Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis. Am J Physiol Cell Physiol. 2018;314(1):C73-C87. DOI: 10.1152/ajpcell.00110.2016. PMID: 27413169.
Stratev V, Petkova D, Dimitrova V, Petev J. Comorbidities of COPD in Bulgarian Patients - Prevalence and Association with Severity and Inflammation. Folia Med (Plovdiv). 2018;60(1):102-9. DOI: 10.1515/folmed-2017-0078. PMID: 29668450.
Di Daniele N. Therapeutic approaches of uncomplicated arterial hypertension in patients with COPD. Pulm Pharmacol Ther. 2015;35:1-7. DOI: 10.1016/j.pupt.2015.09.004. PMID: 26363278.
Greulich T, Weist BJD, Koczulla AR, Janciauskiene S, Klemmer A, Lux W, et al. Prevalence of comorbidities in COPD patients by disease severity in a German population. Respir Med. 2017;132:132-8. DOI: 10.1016/j.rmed.2017.10.007. PMID: 29229085.
Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM, et al. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(9):e56-e69. DOI: 10.1164/rccm.202003-0625ST. PMID: 32283960.
Feshchenko YuI, Havrysiuk VK, Dziublyk OYa, Mostovoi YuM, Pertseva TO, Polianska MO et al. Adapted clinical guideline: chronic obstructive pulmonary disease Ukr. pulmonology journal. 2020;3:5-36. DOI: 10.31215/2306-4927-2020-109-3-5-36.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13-e115. DOI: 10.1161/HYP.0000000000000065. PMID: 29133356.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. DOI: 10.1093/eurheartj/ehy339. PMID: 30165516.
Order of the Ministry of Health No.384 on 24 Jun 2012. Arterial hypertension. Unified clinical protocol for primary, emergency and secondary (specialized) medical care. 2012. 72 р.
Kim SH, Park JH, Lee JK, Heo EY, Kim DK, Chung HS. Chronic obstructive pulmonary disease is independently associated with hypertension in men: A survey design analysis using nationwide survey data. Medicine (Baltimore). 2017;96(19):e6826. DOI: 10.1097/MD.0000000000006826. PMID: 28489760.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.